PExA AB (publ)
PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrum… Read more
PExA AB (publ) (FA0) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.208x
Based on the latest financial reports, PExA AB (publ) (FA0) has a cash flow conversion efficiency ratio of -0.208x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.03 Million) by net assets (€9.77 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PExA AB (publ) - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how PExA AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PExA AB (publ) Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PExA AB (publ) ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dangee Dums Limited
NSE:DANGEE
|
0.132x |
|
Hanil Vacuum Co. Ltd
KQ:123840
|
-0.032x |
|
Hwa Tai Industries Bhd
KLSE:8478
|
-0.040x |
|
JABIL CIRCUIT - Dusseldorf Stock Exchang
DU:JBL
|
0.235x |
|
Oxford Cannabinoid Technologies Holdings Plc
PINK:OCTHF
|
-0.001x |
|
JET CONTRACTORS
BC:JET-CONTRACTORS
|
N/A |
|
X2M Connect Ltd
AU:X2M
|
-0.024x |
|
Talis Biomedical Corp
PINK:TLIS
|
-0.233x |
Annual Cash Flow Conversion Efficiency for PExA AB (publ) (2021–2024)
The table below shows the annual cash flow conversion efficiency of PExA AB (publ) from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €8.23 Million | €-8.32 Million | -1.012x | -41.22% |
| 2023-12-31 | €13.22 Million | €-9.47 Million | -0.716x | -176.98% |
| 2022-12-31 | €21.27 Million | €-5.50 Million | -0.259x | -9.09% |
| 2021-12-31 | €21.90 Million | €-5.19 Million | -0.237x | -- |